ArticleInternational journal of pharmaceutics: X2026
Roadmap for the accelerated development and clinical translation of fluorescent tracers: Adalimumab-680LT as a proof of concept.
Henrik K Huizinga et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.